The Effect of Patient Empowerment Learning (With AI) About Itching in Hemodylasis Patients.

The Effect of Artificial Intelligence-Supported Patient Empowerment Education on Itching in Patients With Chronic Kidney Disease Undergoing Hemodialysis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07740083

Enrollment

128

Registered

2026-07-31

Start date

2025-01-12

Completion date

2026-08-28

Last updated

2026-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronc Kidney Disease Stage 5, Chronic Kidney Disease, Kidney Disease

Keywords

Artificial Intelligence, CKD, Patient Empowerment

Brief summary

This study investigates whether artificial intelligence-supported patient education can reduce itching and improve patient empowerment in individuals with chronic kidney disease undergoing hemodialysis.

Interventions

BEHAVIORALArtificial Intelligence-Supported Patient Education

The intervention consisted of an artificial intelligence-supported patient education program developed for patients with chronic kidney disease undergoing hemodialysis. The education focused on pruritus management and included information about the causes of itching, factors affecting pruritus, skin care, dietary recommendations, symptom management strategies, and self-management behaviors. The educational content was provided through an AI-supported website designed to improve patient empowerment and increase patients' knowledge and participation in their own care.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Intervention model description

We use 5-D Itching Scale and Patient Empowerment Scale for the datas we collect from the patients. Our aim is see the effect of artificial intelligence-supported patient education in CKD patients who take hemodylasis.

Eligibility

Sex/Gender

ALL

Age

18 Weeks to 65 Weeks

Healthy volunteers

Inclusion criteria

Patients with CKD. Patients who have ithing symptom. Patients who is older than 18. Patients who takes hemodylasis treatment regularly and in order.

Exclusion criteria

* Patients who got dementia and alzheimers. * Patients who is older than 65. * Patients who doesnt want to join the study.

Design outcomes

Primary

Measure	Time frame	Description
5-D Itching Scale Score	2 weeks	Changes in 5-D Itching Scale Score

Secondary

Measure	Time frame	Description
Patient Empowerment Scale Score	2 weeks	Changes in Patient Empowerment Scale Score

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 1, 2026